Plasma levels of remnant particles are determined in part by variation in the APOC3 gene insulin response element and the APOCI-APOE cluster

Journal of Lipid Research

Volumn 41, Issue 7, 2000, Pages 1103-1109

  Waterworth, D M ^a   Hubacek, J A ^a,b   Pitha, J ^b   Kovar, J ^b   Poledne, R ^b   Humphries, S E ^a   Talmud, P J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Apolipoprotein B; Hepatic lipase; Insulin response element; Lipoprotein lipase; Remnant like cholesterol; Remnant like triglyceride

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN C1; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; FEMALE; GENE CLUSTER; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN METABOLISM;

ADULT; APOLIPOPROTEINS B; APOLIPOPROTEINS C; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHOLESTEROL; CHYLOMICRON REMNANTS; CHYLOMICRONS; CORONARY DISEASE; CZECH REPUBLIC; DIETARY FATS; FEMALE; HUMANS; INSULIN; LIPASE; LIPOPROTEINS; MALE; MIDDLE AGED; MULTIGENE FAMILY; POLYMORPHISM, GENETIC; POSTPRANDIAL PERIOD; RESPONSE ELEMENTS; TRIGLYCERIDES;

EID: 0033929102     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Hodis, H. N. 1999. Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis. Circulation. 99: 2852-2854.
2. Kugiyama, K., H. Doi, K. Takazoe, H. Kawano, H. Soejima, Y. Mizuno, R. Tsunoda, T. Sakamoto, T. Nakano, K. Nakajima, H. Ogawa, S. Sugiyama, M. Yoshimura, and H. Yasue. 1999. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation. 99: 2858-2860.
3. Nakajima, K., T. Saito, A. Tamura, M. Suzuki, T. Nakano, M. Adachi, A. Tanaka, N. Tada, H. Nakamura, E. Campos, and R. J. Havel. 1993. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apoB-100 and anti apoAI immunoaffinity mixed gels. Clin. Chim. Acta. 223: 53-71.
4. Leary, E. T., T. Wang, D. J. Baker, D. D. Cilla, J. Zhong, G. R. Warnick, K. Nakajima, and R. J. Havel. 1998. Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle cholesterol in serum and plasma. Clin. Chem. 44: 2490-2498.
5. Marcoux, C., M. Tremblay, K. Nakajima, J. Davignon, and J. S. Cohn. 1999. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients. J. Lipid Res. 40: 636-647.
6. McNamara, J. R., P. K. Shah, K. Nakajima, L. A. Cupples, P. W. F. Wilson, J. M. Ordovas, and E. J. Schaefer. 1998. Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study. Clin. Chem. 44: 1224-1232.
7. De Knijff, P., and L. M. Havekes. 1996. Apolipoprotein E as a risk factor for coronary heart disease: a genetic and molecular biology approach. Curr. Opin. Lipidol. 7: 59-63.
8. Luc, G., J. Bard, D. Arveiler, A. Evans, J. Cambou, A. Bingham, P. Amouyel, P. Schaffer, J. Ruidavets, F. Cambien, J. Fruchart, and P. Ducimetiere. 1994. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM study. Arterioscler. Thromb. 14: 1412-1419.
9. Tiret, L., P. De Knijff, H. Menzel, C. Ehnholm, V. Nicaud, and L. M. Havekes. 1994. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. Arterioscler. Thromb. 14: 1617-1624.
10. Xu, Y., L. Bergland, R. Ramakrishnan, R. Mayeux, C. Ngai, S. Holleran, B. Tyoko, T. Leff, and N. S. Schacter. 1999. A common HpaI RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E. J. Lipid Res. 40: 50-58.
11. Weisgraber, K. H., R. W. Mahley, R. C. Kowal, J. L. Herz, J. L. Goldstein, and M. S. Brown. 1990. Apolipoprotein C-I modulates the interaction of apolipoprotein E with B-migrating very low density lipoproteins and inhibits binding of B-VLDL to low density lipoprotein receptor-related protein. J. Biol. Chem. 265: 22453-22459.
12. Seyahek, E., and S. Eisenberg. 1991. Mechanisms of inhibition by apolipoprotein C of of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J. Clin. Chem. Biochem. 266: 18259-18267.
13. Jong, M. C., M. Hofker, and L. M. Havekes. 1999. Role of ApoCs in lipoprotein metabolism. Functional differences between ApoC1, ApoC2 and ApoC3. Arterioscler. Thromb. Vasc. Biol. 19: 472-484.
14. Hodis, H. N., and W. J. Mack. 1995. Triglyceride-rich lipoproteins and the progression of coronary heart disease. Curr. Opin. Lipidol. 6: 209-214.
15. Wang, C., W. J. McConathy, H. U. Kloer, and P. Alaupovic. 1985. Modulation of lipoprotein lipase activity by apolipoproteins. J. Clin. Invest. 75: 384-390.
16. Aalto-Setala, K., E. A. Fisher, X. Chen, T. D. Shaul, T. Hayek, R. Zechner, A. Walsh, R. Ramakrishnan, H. Ginsberg, and J. L. Breslow. 1992. Mechanism of hypertriglyceridemia in human apolipoprotein CIII transgenic mice. J. Clin. Invest. 90: 1889-1890.
17. Surguchov, A. P., G. P. Page, L. Smith, W. Patsch, and E. Boerwinkle. 1996. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 16: 941-947.
18. Li, W. W., M. M. Dammerman, J. D. Smith, S. Metzger, J. L. Breslow, and T. Leff. 1995. Common genetic variation in the promoter of the human apoCIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J. Clin. Invest. 96: 2601-2605.
19. Hegele, R. A., P. W. Connelly, A. J. G. Hanley, F. Sun, S. B. Harris, and B. Zinman. 1997. Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins. Arterioscler. Thromb. Vasc. Biol. 17: 2753-2758.
20. Fisher, R. M., S. E. Humphries, and P. J. Talmud. 1997. Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis. 135: 145-159.
21. Humphries, S. E., V. Nicaud, J. Margalef, I. Tiret, and P. J. Talmud. 1998. Lipoprotein lipase gene variation is associated with paternal history of premature coronary artery disease and lasting and postprandial plasma triglycerides. Arterioscler. Thromb. Vasc. Biol. 18: 526-534.
22. Chang, S., and J. Borensztajn. 1995. Uptake of chylomicron-remnants and hepatic lipase-treated chylomicrons by a non-transformed murine hepatocyte cell line in culture. Biochim. Biophys. Acta. 1256: 81-87.
23. Krapp, A., S. Ahle, S. Kersting, Y. Hua, K. Kneser, M. Nielsen, J. Gliemann, and U. Beisegel. 1996. Hepatic lipase mediates the uptake of chylomicrons and beta-VLDL into cells via the LDL receptor related protein (LRP). J. Lipid Res. 37: 926-936.
24. Jansen, H., A. J. M. Verhoeven, L. Weeks, J. J. P. Kastelein, D. J. J. Halley, A. van den Ouweland, J. W. Jukema, J. C. Seidell, and J. C. Birkenhager. 1997. Common C- to T-substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler. Thromb. Vasc. Biol. 17: 2837-2842.
25. Jansen, H., G. Chu, C. Ehnholm, J. Dallongeville, V. Nicaud, and P. J. Talmud. 1999. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B. Arterioscler. Thromb. Vasc. Biol. 19: 303-308.
26. Sturley, S. L., P. J. Talmud, R. Brasseur, M. R. Culbertson, S. E. Humphries, and A. D. Attie. 1994. Human apolipoprotein B signal peptide sequence variants confer a secretion-defective phenotype when expressed in yeast. J. Biol. Chem. 269: 21670-21675.
27. Peacock, R. E., F. Karpe, P. J. Talmud, A. Hamsten, and S. E. Humphries. 1995. Common variation in the gene for apolipoprotein B modulates postprandial lipoprotein metabolism: a hyothesis generating study. Atherosclerosis. 116: 135-145.
28. World Health Organization. 1983. Multinational monitoring of trends and determinants in cardiovascular diseases: MONICA project. In Manual of Operations. WHO/MNC 82.2. World Health Organization, Geneva, Switzerland.
29. Waterworth, D. M., J. Ribalta, M. A. Nicaud, J. Dallongeville, S. E. Humphries, and P. J. Talmud. 1999. ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests. Circulation. 99: 1872-1877.
30. Hixson, J. E., and D. T. Vernier. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31: 545-548.
31. Nillesen, W. N., H. J. M. Smeets, and B. A. van Oost. 1990. Human apoCI HpaI restriction site polymorphism revealed by the polymerase chain reaction. Nucleic Acids Res. 11: 3428.
32. Xu, C. F., M. J. Tikkanen, J. K. Huttunen, P. Pietinen, R. Bulter, and S. Humphries. 1990. Apolipoprotein B signal peptide insertion/deletion polymorphism is associated with Ag epitopes and involved in the determination of serum triglyceride levels. J. Lipid Res. 31: 1255.
33. Day, I. N. M., and S. E. Humphries. 1994. Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Anal. Biochem. 222: 389-395.
34. Chakravarti, A., K. H. Buetow, S. E. Antonarakis, P. G. Waber, C. D. Boehm, and H. H. Kazazian. 1984. Nonuniform recombination within the human beta-globin gene cluster. Am. J. Hum. Genet. 36: 1239-1258.
35. Ebara, T., R. Ramakrishnan, G. Steiner, and N. S. Schacter. 1997. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. J. Clin. Invest. 99: 2672-2681.
36. Lai, E., J. Riley, I. Purvis, and A. Roses. 1998. A 4-Mb high-density single nucleotide polymorphism-based map around human apoE. Genomics. 54: 31-38.
37. Wilson, P. W. F., E. J. Schaefer, M. G. Larson, and J. M. Ordovas. 1996. Apolipoprotein E alleles and risk of coronary disease. Arterioscler. Thromb. Vasc. Biol. 16: 1250-1255.